Profile data is unavailable for this security.
About the company
Promimic AB is a Sweden-based biomaterial company. The Company manufactures, markets and sells biomaterials for improved osseointegration (bone healing) to the companies in the markets for orthopedic and dental implants. The Company operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets.
- Revenue in SEK (TTM)37.07m
- Net income in SEK-9.22m
- Incorporated2004
- Employees17.00
- LocationPromimic ABc/o AstraZeneca R&D MolndalMOELNDAL 431 83SwedenSWE
- Phone+46 31160860
- Websitehttps://promimic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ascelia Pharma AB | 0.00 | -109.29m | 313.27m | 13.00 | -- | 4.35 | -- | -- | -3.20 | -3.20 | 0.00 | 2.13 | 0.00 | -- | -- | 0.00 | -71.51 | -- | -85.53 | -- | -- | -- | -- | -- | -- | -- | 0.0141 | -- | -- | -- | 16.72 | -- | -- | -- |
Herantis Pharma Oyj | 0.00 | 3.26m | 328.77m | 10.00 | 111.38 | 5.97 | 100.86 | -- | 0.0126 | 0.0126 | 0.00 | 0.2344 | 0.00 | -- | -- | 0.00 | 4.31 | -80.46 | 6.16 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | 103.00 | -- | -- | -- |
Intervacc AB | 8.02m | -102.85m | 329.45m | 15.00 | -- | 1.38 | -- | 41.10 | -1.47 | -1.47 | 0.1167 | 3.14 | 0.0306 | 3.08 | 1.72 | 534,333.30 | -39.21 | -17.62 | -42.12 | -18.77 | -628.60 | -243.59 | -1,283.24 | -626.90 | 4.38 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
Medivir AB | 7.73m | -96.52m | 335.04m | 10.00 | -- | 1.58 | -- | 43.33 | -1.46 | -1.46 | 0.1028 | 1.89 | 0.032 | -- | 1.56 | 773,300.00 | -40.00 | -28.91 | -47.20 | -34.77 | -888.81 | -467.42 | -1,248.18 | -675.96 | -- | -- | 0.0482 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
Magle Chemoswed Holding AB | 170.01m | 12.23m | 347.76m | 78.00 | 28.44 | 2.15 | 13.88 | 2.05 | 1.13 | 1.13 | 15.74 | 14.95 | 0.6068 | 0.493 | 8.30 | 2,179,628.00 | 4.36 | 2.52 | 5.86 | 3.52 | 90.58 | 85.67 | 7.19 | 3.92 | 0.6356 | 6.35 | 0.3081 | -- | 17.00 | 9.97 | 33.07 | -- | -6.34 | -- |
Lifecare ASA | 13.13m | -35.37m | 418.72m | 32.00 | -- | 6.29 | -- | 31.90 | -0.2903 | -0.2903 | 0.1088 | 0.4924 | 0.1621 | -- | 4.90 | 408,943.10 | -43.60 | -40.00 | -49.97 | -45.26 | -- | -- | -269.03 | -175.53 | -- | -- | 0.1812 | -- | -40.88 | 30.29 | -101.74 | -- | -- | -- |
INIFY Laboratories AB | 3.42m | -51.39m | 427.00m | 23.00 | -- | 5.84 | -- | 124.90 | -1.13 | -1.13 | 0.0753 | 1.61 | 0.032 | 2.99 | 0.6608 | -- | -48.10 | -- | -48.10 | -- | 76.42 | -- | -1,503.10 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Mendus AB (publ) | 0.00 | -101.62m | 450.21m | 30.00 | -- | 0.5475 | -- | -- | -0.2554 | -0.2554 | 0.00 | 0.8165 | 0.00 | -- | -- | 0.00 | -14.77 | -18.84 | -15.78 | -20.21 | -- | -- | -- | -28,474.53 | -- | -- | 0.0325 | -- | -100.00 | -- | 26.78 | -- | -- | -- |
Initiator Pharma A/S | 0.00 | -35.69m | 476.27m | 2.00 | -- | 27.12 | -- | -- | -0.6567 | -0.6567 | 0.00 | 0.3319 | 0.00 | -- | -- | 0.00 | -58.55 | -65.10 | -62.50 | -70.59 | -- | -- | -- | -- | -- | -- | 0.5804 | -- | -- | -- | 40.52 | -- | -- | -- |
Promimic AB | 37.07m | -9.22m | 485.09m | 17.00 | -- | 6.32 | -- | 13.09 | -0.5283 | -0.5283 | 2.08 | 4.11 | 0.3994 | -5.63 | 3.00 | 2,180,588.00 | -9.93 | -24.89 | -11.67 | -29.25 | 103.90 | 101.23 | -24.88 | -89.47 | 3.98 | -- | 0.00 | -- | 128.63 | -- | 41.95 | -- | -- | -- |
Bergenbio ASA | 355.11k | -191.00m | 512.08m | 18.00 | -- | 2.75 | -- | 1,442.03 | -0.2647 | -0.2647 | 0.0002 | 0.0474 | 0.0021 | -- | -- | -- | -111.66 | -66.15 | -176.09 | -78.74 | -- | -- | -53,785.59 | -11,419.44 | -- | -- | 0.00 | -- | -9.00 | -31.43 | 36.98 | -- | -- | -- |
Enzymatica AB (publ) | 47.29m | -53.67m | 549.62m | 18.00 | -- | 6.55 | -- | 11.62 | -0.3247 | -0.3247 | 0.2866 | 0.4841 | 0.3269 | 1.38 | 6.48 | -- | -37.11 | -27.36 | -39.16 | -33.98 | 64.25 | 65.08 | -113.50 | -66.12 | -- | -23.26 | 0.2502 | -- | 4.00 | -0.6382 | 27.57 | -- | 7.02 | -- |
Hamlet BioPharma AB | 0.00 | -26.59m | 573.66m | 7.00 | -- | 12.67 | -- | -- | -0.207 | -0.207 | 0.00 | 0.3543 | 0.00 | -- | -- | -- | -63.29 | -83.52 | -69.05 | -107.84 | -- | -- | -- | -- | -- | -- | 0.0984 | -- | -- | -- | -18.87 | -- | 78.01 | -- |
Oncopeptides AB | 35.22m | -249.11m | 586.65m | 57.00 | -- | 6.21 | -- | 16.66 | -1.96 | -1.96 | 0.2776 | 0.4474 | 0.1129 | -- | 1.44 | 617,894.80 | -79.88 | -141.28 | -101.04 | -200.49 | 103.06 | -- | -707.30 | -2,689.06 | -- | -- | 0.7065 | -- | 321.54 | -- | 26.29 | -- | -- | -- |
Gentian Diagnostics ASA | 142.67m | -5.85m | 587.89m | 58.00 | -- | 3.87 | 163.70 | 4.12 | -0.3783 | -0.3783 | 9.22 | 9.82 | 0.7646 | 1.85 | 6.35 | 2,452,035.00 | -3.14 | -10.76 | -3.58 | -11.86 | 50.84 | 41.46 | -4.10 | -26.99 | 4.14 | -- | 0.0555 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
Data as of May 16 2024. Currency figures normalised to Promimic AB's reporting currency: Swedish Krona SEK
Holder | Shares | % Held |
---|---|---|
Andra AP-fondenas of 31 Dec 2023 | 958.09k | 5.20% |
Swedbank Robur Fonder ABas of 31 Dec 2023 | 624.00k | 3.39% |
Protean Funds Scandinavia ABas of 31 Dec 2023 | 310.33k | 1.69% |
Schroder Investment Management Ltd.as of 30 Jun 2023 | 89.67k | 0.49% |
More ▼
Data from 15 Feb 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.